These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 11120722

  • 1. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Seed M, Sands RH, McLaren M, Kirk G, Darko D.
    Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
    [Abstract] [Full Text] [Related]

  • 2. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ, Flight IH, Rees MC.
    Cochrane Database Syst Rev; 2000 Dec; (2):CD001018. PubMed ID: 10796730
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy.
    Darko DA, Dornhorst A, Kennedy G, Mandeno RC, Seed M.
    Diabetes Res Clin Pract; 2001 Dec; 54(3):157-64. PubMed ID: 11689270
    [Abstract] [Full Text] [Related]

  • 5. Type and route of estrogen administration.
    Stevenson JC.
    Climacteric; 2009 Dec; 12 Suppl 1():86-90. PubMed ID: 19811249
    [Abstract] [Full Text] [Related]

  • 6. The effect of hormone replacement therapy of the age-related rise of factor VIIc, and its activity state.
    Wright D, Poller L, Thomson JM, Burrows GE, Hirst CF, Sidebotham A.
    Thromb Res; 1997 Mar 15; 85(6):455-64. PubMed ID: 9101638
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women.
    McCrohon JA, Adams MR, McCredie RJ, Robinson J, Pike A, Abbey M, Keech AC, Celermajer DS.
    Clin Endocrinol (Oxf); 1996 Oct 15; 45(4):435-41. PubMed ID: 8959082
    [Abstract] [Full Text] [Related]

  • 8. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P, Galanis P, Chatzistergiou V, Stevenson JC, Godsland IF, Lambrinoudaki I, Theodorou M, Goulis DG.
    Maturitas; 2017 May 15; 99():27-36. PubMed ID: 28364865
    [Abstract] [Full Text] [Related]

  • 9. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V, Bull D, Reeves G, Million Women Study Collaborators.
    Lancet; 2017 May 15; 365(9470):1543-51. PubMed ID: 15866308
    [Abstract] [Full Text] [Related]

  • 10. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
    Bingol B, Gunenc Z, Yilmaz M, Biri A, Tiras B, Güner H.
    Arch Gynecol Obstet; 2010 May 15; 281(5):857-64. PubMed ID: 19593578
    [Abstract] [Full Text] [Related]

  • 11. Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers.
    Stevenson JC, Oladipo A, Manassiev N, Whitehead MI, Guilford S, Proudler AJ.
    Br J Haematol; 2004 Mar 15; 124(6):802-8. PubMed ID: 15009069
    [Abstract] [Full Text] [Related]

  • 12. Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
    Brosnan JF, Sheppard BL, Norris LA.
    Thromb Haemost; 2007 Apr 15; 97(4):558-65. PubMed ID: 17393018
    [Abstract] [Full Text] [Related]

  • 13. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S, Selby PL, McElduff P, Laing I, Mackness B, Mackness MI, Prais H, Morgan J, Yates AP, Durrington PN, Sci FM.
    Clin Endocrinol (Oxf); 2004 Dec 15; 61(6):760-7. PubMed ID: 15579192
    [Abstract] [Full Text] [Related]

  • 14. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec 15; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 15. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 15; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 16. Effects of oral combined hormone replacement therapy on plasma lipids and lipoproteins.
    Vadlamudi S, MacLean P, Israel RG, Marks RH, Hickey M, Otvos J, Barakat H.
    Metabolism; 1998 Oct 15; 47(10):1222-6. PubMed ID: 9781625
    [Abstract] [Full Text] [Related]

  • 17. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
    Renoux C, Dell'aniello S, Garbe E, Suissa S.
    BMJ; 2010 Jun 03; 340():c2519. PubMed ID: 20525678
    [Abstract] [Full Text] [Related]

  • 18. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
    Oger E, Alhenc-Gelas M, Plu-Bureau G, Mennen L, Cambillau M, Guize L, Pujol Y, Scarabin P.
    Thromb Res; 2001 Jan 15; 101(2):35-43. PubMed ID: 11342204
    [Abstract] [Full Text] [Related]

  • 19. Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy.
    Falcó C, Tormo G, Estellés A, España F, Tormo E, Gilabert J, Velasco JA, Aznar J.
    Haematologica; 2001 Jan 15; 86(1):92-8. PubMed ID: 11146577
    [Abstract] [Full Text] [Related]

  • 20. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V, Million Women Study Collaborators.
    Lancet; 2003 Aug 09; 362(9382):419-27. PubMed ID: 12927427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.